Quidel | QDEL - Assets


Quidel reported $5.78B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Danaher USD 93.28B 914M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
Illumina USD 6.81B 162M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Mettler Toledo International USD 3.7B 24.53M Sep/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Neogen USD 3.3B 42.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
STAAR Surgical USD 485.16M 9.95M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Waters USD 24.12B 636M Sep/2026